Weiqun Xu
- Hematology top 5%
- Immunology
- Public Health, Environmental and Occupational Health top 10%
- Infectious Diseases top 10%
- Oncology
- Topics
- Acute Lymphoblastic Leukemia research (17 papers)Acute Myeloid Leukemia Research (13 papers)Immune Cell Function and Interaction (9 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Weiqun Xu
53 papers receiving 604 citations
Peers
Comparison fields: 5 of 71
- Hematology 310
- Immunology 207
- Public Health, Environmental and Occupational Health 151
- Infectious Diseases 143
- Oncology 112
Countries citing papers authored by Weiqun Xu
This map shows the geographic impact of Weiqun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqun Xu more than expected).
Fields of papers citing papers by Weiqun Xu
This network shows the impact of papers produced by Weiqun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqun Xu. The network helps show where Weiqun Xu may publish in the future.
Co-authorship network of co-authors of Weiqun Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Weiqun Xu. A scholar is included among the top collaborators of Weiqun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqun Xu. Weiqun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 4 | |
| 11 | 10 | |
| 12 | 13 | |
| 13 | 1 | |
| 14 | 12 | |
| 15 | 5 | |
| 16 | 5 | |
| 17 | 21 | |
| 18 | 41 | |
| 19 | 173 | |
| 20 | [Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia]. | 4 |
About Weiqun Xu
Weiqun Xu is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health, having authored 56 papers that have together received 617 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (17 papers), Acute Myeloid Leukemia Research (13 papers) and Immune Cell Function and Interaction (9 papers). The work is most often cited by research in Hematology (310 citations), Immunology (207 citations) and Infectious Diseases (143 citations). Weiqun Xu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Hua Song, Xiaojun Xu, Shilong Yang, Yongmin Tang, Shuwen Shi, Yongmin Tang, Lingyan Zhang, Ning Zhao, Heping Shen and Binhua Pan. Their work appears in journals such as Nature Communications, Blood and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.